These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2323852)

  • 1. Identification of T-cell antigens expressed by metastatic T-cell hybridomas and lymphomas.
    Van Hecke D; Verschueren H; De Baetselier P
    Int J Cancer; 1990 Apr; 45(4):773-82. PubMed ID: 2323852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metastatic T-cell hybridoma antigen/P-selectin glycoprotein ligand 1 is required for hematogenous metastasis of lymphomas.
    Raes G; Ghassabeh GH; Brys L; Mpofu N; Verschueren H; Vanhecke D; De Baetselier P
    Int J Cancer; 2007 Dec; 121(12):2646-52. PubMed ID: 17721882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells.
    Ohnishi K; Bonavida B
    J Immunol; 1986 Jul; 137(2):733-40. PubMed ID: 2424977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface sialic acid and the invasive and metastatic potential of T-cell hybridomas.
    Collard JG; Schijven JF; Bikker A; La Riviere G; Bolscher JG; Roos E
    Cancer Res; 1986 Jul; 46(7):3521-7. PubMed ID: 3486712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquisition of high metastatic capacity after in vitro fusion of a nonmetastatic tumor line with a bone marrow-derived macrophage.
    Larizza L; Schirrmacher V; Pflüger E
    J Exp Med; 1984 Nov; 160(5):1579-84. PubMed ID: 6491605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syngeneic in vivo passage of the murine BW 5147 lymphoma results in the expression of a stable metastatic phenotype.
    De Baetselier P; Roos E; van Hecke D; Verschaeve L; Brys L; Verschueren H
    Int J Cancer; 1988 May; 41(5):720-6. PubMed ID: 3259210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An attempt to produce "pre-T" cell hybridomas and to identify their antigens.
    Aihara Y; Bühring HJ; Aihara M; Klein J
    Eur J Immunol; 1986 Nov; 16(11):1391-9. PubMed ID: 3096743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Several new monoclonal antibodies directed to human T-cell leukemia antigens.
    Negoro S; Seon BK
    Cancer Res; 1982 Oct; 42(10):4259-62. PubMed ID: 6980703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonmetastatic tumor cells acquire metastatic properties following somatic hybridization with normal cells.
    De Baetselier P; Roos E; Brys L; Remels L; Gobert M; Dekegel D; Segal S; Feldman M
    Cancer Metastasis Rev; 1984; 3(1):5-24. PubMed ID: 6370419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and classification of hematologic tumors using anti-lymphocyte monoclonal antibodies].
    Kikuchi K
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):551-8. PubMed ID: 6603817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of T hybridomas prepared from a T cell clone with three specificities. Recognition of self + X and allo-H-2 determinants segregates from recognition of Mlsa determinants.
    Webb SR; Okamoto A; Sprent J
    J Immunol; 1988 Sep; 141(6):1828-34. PubMed ID: 2459192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasiveness of T-cell hybridomas in vitro and their metastatic potential in vivo.
    Roos E; La Rivière G; Collard JG; Stukart MJ; De Baetselier P
    Cancer Res; 1985 Dec; 45(12 Pt 1):6238-43. PubMed ID: 3877565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cell surface antigens by suppressor T cell hybridomas. I. Comparison of phenotype and function.
    Trial J; Kapp JA; Pierce CW; Shreffler DC; Sorensen CM; Waltenbaugh C
    J Immunol; 1983 Feb; 130(2):565-72. PubMed ID: 6217244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse monoclonal antibodies detecting disialogangliosides on mouse and human T lymphomas.
    Kawashima I; Tada N; Ikegami S; Nakamura S; Ueda R; Tai T
    Int J Cancer; 1988 Feb; 41(2):267-74. PubMed ID: 2448252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasiveness in hepatocyte and fibroblast monolayers and metastatic potential of T-cell hybridomas in mice.
    la Rivière G; Schipper CA; Collard JG; Roos E
    Cancer Res; 1988 Jun; 48(12):3405-10. PubMed ID: 3285995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Putative invasion-specific proteins in mouse T-cell hybridomas that differ in invasive and metastatic potential.
    La Rivière G; Schipper CA; Gebbinck JW; Koch G; Kuhn L; Lefkovits I; Roos E
    Int J Cancer; 1992 Jul; 51(5):745-53. PubMed ID: 1612783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method for rapid detection of membrane antigens by immunofluorescence and its application to screening monoclonal antibodies.
    Boucheix C; Krief P; Perrot JY; Mirshahi M; Rosenfeld C
    Methods Enzymol; 1986; 121():580-7. PubMed ID: 3523133
    [No Abstract]   [Full Text] [Related]  

  • 18. Establishment of B cell hybridomas with B cell surface antigens.
    Hamano T; Kim KJ; Leiserson WM; Asofsky R
    J Immunol; 1982 Oct; 129(4):1403-6. PubMed ID: 6809823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of thymocyte MHC specificity with thymocyte hybridomas.
    Yeh ET; Benacerraf B; Rock KL
    J Exp Med; 1984 Sep; 160(3):799-813. PubMed ID: 6206189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of hen egg white lysozyme (HEL)-specific delayed type hypersensitivity hybridomas.
    Ishii N; Aoki I; Aihara Y; Hikawa N; Takahashi T; Okuda K
    Hybridoma; 1985; 4(4):311-8. PubMed ID: 2415445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.